The vial thawing protocol in the cell therapy industry is an unstandardized and variable process. Biocision identified clinical tools for pharmaceutical, biotechnology, and other healthcare industries to standardize and automate. The first platform to transform and automate the 40+ year conventional water bath thawing process was the ThawSTAR. Such a device is convenient in a GMP setting where water baths are generally avoided due to the potential contamination risk.
BioCison tasked Gener8’s engineers to architect, and develop a low-cost instrument to replace existing water bath solutions. Our integrated end-to-end design to manufacturing capabilities enabled the customer to go from proof-of-concept to Beta testing units in only four months and with early low- to mid-manufacturing in six-eight months.